The Transcatheter Cardiovascular Therapeutics (TCT) 33rd annual meeting is in the books, and there’s a lot of great information that came out of it. But with any TCT meeting, the data and studies presented are dense and can be overwhelming.

Not to worry, because the editors at MD+DI have combed through analysts’ reports, press releases, company websites, and TCT’s website, to compile a list of the most important developments at this year’s event.